Q2 2023 Holdings
Filed 2023-08-14 | 101 holdings | $4.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medtech Acquisition Corp | UNIT 12/18/2025 | 58507N204 | $10 | 1 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $9.2K | 166,666 | 0.0% |
| Medtech Acquisition Corp | *W EXP 12/22/202 | 58507N113 | $14.0K | 333,333 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $27.6K | 166,666 | 0.0% |
| Sientra Inc | COM | 82621J204 | $29.3K | 10,000 | 0.0% |
| Somalogic Inc | *W EXP 08/31/202 | 83444K113 | $30.0K | 120,000 | 0.0% |
| The Oncology Institute Inc(TOIIW) | *W EXP 11/15/202 | 68236X118 | $34.9K | 1,250,000 | 0.0% |
| Quantum SI Inc | *W EXP 06/10/202 | 74765K113 | $76.7K | 333,333 | 0.0% |
| Butterfly Network Inc(BFLYW) | *W EXP 02/12/202 | 124155110 | $172.7K | 733,333 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $193.9K | 92,787 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $205.1K | 836,626 | 0.0% |
| Caremax Inc | *W EXP 06/08/202 | 14171W111 | $259.4K | 672,000 | 0.0% |
| Calcimedica Inc(CALC) | COM NEW | 38942Q202 | $1.1M | 265,657 | 0.0% |
| Quantum SI Inc(QSI) | COM CL A | 74765K105 | $1.4M | 797,500 | 0.0% |
| Orchard Therapeutics PLC | SPON ADS NEW | 68570P200 | $1.6M | 316,169 | 0.0% |
| The Oncology Institute Inc(TOI) | COM | 68236X100 | $1.8M | 3,360,052 | 0.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $2.1M | 583,913 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $2.1M | 1,381,416 | 0.0% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $2.4M | 2,660,808 | 0.1% |
| Roivant Sciences LTD | *W EXP 09/30/202 | G76279119 | $2.5M | 1,000,000 | 0.1% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $3.5M | 869,565 | 0.1% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $3.6M | 455,262 | 0.1% |
| Singular Genomics Systems in | COM | 82933R100 | $5.4M | 6,450,871 | 0.1% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $5.5M | 777,525 | 0.1% |
| Neogenomics Inc | NOTE 1.250% 5/0 | 64049MAA8 | $6.1M | $6,500,000 | 0.1% |
| Alector Inc(ALEC) | COM | 014442107 | $6.3M | 1,055,192 | 0.1% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $7.5M | 1,253,895 | 0.2% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $9.1M | 1,800,000 | 0.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $9.3M | 1,322,000 | 0.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $9.4M | 656,000 | 0.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $9.5M | 2,885,400 | 0.2% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $10.5M | 5,854,860 | 0.2% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $10.6M | 1,842,000 | 0.2% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $11.4M | 225,000 | 0.2% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $11.4M | 1,538,461 | 0.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $11.7M | 650,000 | 0.3% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $12.5M | 613,000 | 0.3% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $13.0M | 885,314 | 0.3% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $13.1M | 1,400,352 | 0.3% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $13.2M | 2,823,000 | 0.3% |
| Acelyrin Inc | COM | 00445A100 | $13.6M | 650,000 | 0.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $13.7M | 1,354,974 | 0.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $13.9M | 658,546 | 0.3% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $14.0M | 1,064,285 | 0.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $14.3M | 837,000 | 0.3% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $15.2M | 1,269,992 | 0.3% |
| Invitae Corp | NOTE 2.000% 9/0 | 46185LAB9 | $15.3M | $17,211,000 | 0.3% |
| Da32 Life Scnce TEC Acqstn C | CLASS A COM | 23312M106 | $16.4M | 1,600,000 | 0.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $16.6M | 1,898,743 | 0.4% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $17.6M | 594,989 | 0.4% |